Incubators & VCs Value proposition
Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie
Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health.
Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of knowledge emerging from the Inserm research laboratories to the industrial world, from invention disclosure to industrial partnerships and startups incorporation.
Inserm Transfert also offers services relating to setting up and managing national, European and international projects, as well as supporting the technology transfer of clinical research and health data/databases.
In 2009, Inserm Transfert and Inserm established an investment fund to finance proofs of concept. In 2005, Inserm Transfert Initiative, a dedicated seed money fund for life sciences, was created. Since 2017 a pathway for pre-entrepreneurship supports researchers/inventors that aspire to become involved in entrepreneurship.
Knowledge Transfer, R&D, Licensing, Partnerships, European & International Research Projetcs, Public Health, techtransfert, valorisation, lifescience, and biotechnologyOriginal language
Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie
Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health.
Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of knowledge emerging from the Inserm research laboratories to the industrial world, from invention disclosure to industrial partnerships and startups incorporation.
Inserm Transfert also offers services relating to setting up and managing national, European and international projects, as well as supporting the technology transfer of clinical research and health data/databases.
In 2009, Inserm Transfert and Inserm established an investment fund to finance proofs of concept. In 2005, Inserm Transfert Initiative, a dedicated seed money fund for life sciences, was created. Since 2017 a pathway for pre-entrepreneurship supports researchers/inventors that aspire to become involved in entrepreneurship.
Inserm Transfert - Accueil
Inserm Transfert, fondée en 2000, est la filiale privée de l’Inserm spécialisée dans le transfert de technologies en sciences de la vie
http://www.inserm-transfert.fr/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 18 Apr 2024 | | |
 | Réseau SATT | Other 31 Mar 2024 | | |
 | Agence du numérique en santé | Other 15 Apr 2024 | | |
 Creative Valley IT Services and IT Consulting | Creative Valley IT Services and IT Consulting | Other 14 Mar 2024 | | |
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 20 Feb 2024 | | |
 SATT CONECTUS Research, Research Services | SATT CONECTUS Research, Research Services | Other 7 Feb 2024 | | |
 | Toulouse Tech Transfer | Other 30 Mar 2024 | | |
 | SATT Nord | Other 18 Apr 2024 | | |
 | Aquitaine Science Transfert (SATT Aquitaine) | Other 10 Apr 2024 | | |
 | SATT AxLR | Other 9 Apr 2024 | | |